Introduction
Iboga, its total alkaloid extract (TA), and the isolated compound ibogaine are natural substances derived from the Tabernanthe iboga plant. Recognized for their profound psychotropic effects and potential therapeutic applications1, they occupy a complex space in the world's legal landscape. This post will explore the legal intricacies of Iboga, Iboga TA, and Ibogaine in Canada, the USA, and Mexico.
Understanding Iboga, Iboga TA, and Ibogaine Laws in Canada
Under Canadian law, ibogaine is classified as a Schedule III substance under the Controlled Drugs and Substances Act2. This regulation applies to ibogaine and substances containing ibogaine, which implies that both Iboga and Iboga TA are regulated under this law.
Recently, Canada has shown a growing acceptance of psychedelics' therapeutic potential, as evidenced by recent exemptions granted for psilocybin use in end-of-life care3. While these changes don't directly impact the legal status of ibogaine, it does indicate a potential shift toward a more liberal stance on psychedelics.
Iboga, Iboga TA, and Ibogaine: The Legal Landscape in the USA
In the United States, ibogaine is classified as a Schedule I substance under the Controlled Substances Act4. This category indicates a high potential for abuse, no accepted medical use in treatment, and a lack of accepted safety for use under medical supervision. This law also covers substances containing ibogaine, including Iboga and Iboga TA.
However, the decriminalization of natural psychedelics has been gaining momentum in several states and cities, such as Oregon and Washington D.C5. It's important to note that these changes don't currently extend to substances like Iboga, Iboga TA, or Ibogaine.
Exploring Iboga, Iboga TA, and Ibogaine Legislation in Mexico
In Mexico, Iboga, Iboga TA, and Ibogaine aren't explicitly listed as controlled substances under the General Health Law6. However, the law's interpretation could potentially classify these substances under a general clause for substances producing similar effects to scheduled drugs.
While the 2018 Supreme Court ruling marked a progressive shift in drug policy with regards to recreational marijuana use7, this leniency hasn't been explicitly extended to substances like Iboga, Iboga TA, or Ibogaine.
The Intersection of Law and Science: An Evolving Relationship
As research into psychedelic substances continues to grow, the relationship between scientific study and drug legislation is becoming increasingly intertwined. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) contribute significantly to the education and research around substances like Iboga, potentially influencing future policy changes8.
Conclusion
Navigating the legal status of Iboga, Iboga TA, and Ibogaine requires a careful understanding of international drug legislation. As our knowledge of these substances evolves, so too will the laws that govern their use. At TripSafely, we continue to advocate for the safe, responsible, and law-abiding use of psychedelics.
Stay informed on the shifting legal and scientific landscape of psychedelics by subscribing to our weekly newsletter on the TripSafely website. We're here to support your journey with expert guidance and integration services.
Footnotes
Alper, K. R., Lotsof, H. S., Frenken, G. M., Luciano, D. J., & Bastiaans, J. (1999). Treatment of Acute Opioid Withdrawal with Ibogaine. American Journal on Addictions, 8(3), 234–242. ↩
Government of Canada. (2021). Controlled Drugs and Substances Act (S.C. 1996, c. 19). Justice Laws Website. https://laws-lois.justice.gc.ca/eng/acts/C-38.8/ ↩
Health Canada. (2020). Exemptions Granted Under Section 56(1) of the Controlled Drugs and Substances Act. https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/exemptions.html ↩
United States Department of Justice. (2020). Controlled Substances - Alphabetical Order. https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf ↩
Decriminalize Nature. (2020). Decriminalize Nature: Plant and Fungi-based Medicines. https://decriminalizenature.org/ ↩
Government of Mexico. (2021). Ley General de Salud. http://www.diputados.gob.mx/LeyesBiblio/pdf/LGS_270421.pdf ↩
Supreme Court of Justice of the Nation. (2018). The General Declaration of Unconstitutionality 1/2018 Issued by the First Chamber of the Supreme Court of Justice of the Nation. https://www.scjn.gob.mx/ ↩
Multidisciplinary Association for Psychedelic Studies. (2021). Research. https://maps.org/research ↩
Comments